Palavra-chave: LYMPHOMA

PROGNOSIS MALIGNANCY CHILDREN AGGRESSIVE NON-HODGKIN TCELL BRAZIL PROJECT LATIN-AMERICAN GROUO OF LYMPHOMAS (GELL) ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS ADOLESCENT KILLER CELLS T-CELL/EPIDEMIOLOGY NON-HODGKIN HODGKIN DISEASE/DRUG THERAPY CENTRAL NERVOUS SYSTEM ADMINISTRATION & DOSAGE DIFUSE LARGE B-CELL LYMPHOMA TONSILLAR ASYMMETRY IMMUNOPHENOTYPING PROGNOSTIC FACTOR CRANIAL NERVES T-CELL PROJECT LYMPH NODE GENE THETA 1 (GSTT1) CUTIS LAXA METHOTREXATE KINASE IMMUNOPHENOTYPE TONSILLAR NEOPLASM HEMATOPOIETIC STEM CELL TRANSPLANTATION T-CELL/PATHOLOGY THERAPEUTIC T/NK-CELL TONSIL LYMPHOMA NON-HODGKIN IMMUNOHISTOCHEMISTRY UNILATERAL TONSILAR ENLARGMENT DNA-ANEUPLOIDY ANAPLASTIC DNA RECEPTOR INTRATHECAL TRANSPLANTATION GLUTATHIONE S-TRANSFERASE MU1 NCCN-IPI RITUXIMAB POLYMORPHISMS LYMPHADENOPHATY TRANSPLANTATION, AUTOLOGOUS AUTOLOGOUS NON-HODGKIN LYMPHOMA BRAZILIANS PRE RITUXIMAB ERA DIFFUSE B-CELL PHENOTYPING NON-HODGKIN´S HEMATOLOGIC NEOPLASM AGNORS MAGNETIC RESSONANCE MORPHOLOGY HLA NATURAL-KILLER CELL PROLIFERATION PALATINE TONSILS